TH164760A - N-acetyl cysteine tablets that can be swallowed. - Google Patents
N-acetyl cysteine tablets that can be swallowed.Info
- Publication number
- TH164760A TH164760A TH1501007009A TH1501007009A TH164760A TH 164760 A TH164760 A TH 164760A TH 1501007009 A TH1501007009 A TH 1501007009A TH 1501007009 A TH1501007009 A TH 1501007009A TH 164760 A TH164760 A TH 164760A
- Authority
- TH
- Thailand
- Prior art keywords
- acetyl cysteine
- swallowed
- additive
- tablets
- granulation
- Prior art date
Links
- 229960004308 ACETYLCYSTEINE Drugs 0.000 title claims abstract 5
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 title claims abstract 5
- 239000000546 pharmaceutic aid Substances 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 238000007908 dry granulation Methods 0.000 claims abstract 2
- 238000005469 granulation Methods 0.000 claims abstract 2
- 230000003179 granulation Effects 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims abstract 2
- 239000008188 pellet Substances 0.000 claims abstract 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive Effects 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
Abstract
การประดิษฐ์นี้จะเกี่ยวข้องกับเม็ดที่สามารถกลืนได้ที่มีอย่างน้อยที่สุด 80% โดยน้ำหนักของ N-อะซีติลซิสเทอีน (NAC) และส่วนเติมเนื้อยาที่ยอมรับได้ทางเภสัชกรรมอย่างน้อยที่สุดหนึ่งชนิด, โดยเฉพาะอย่างยิ่ง เม็ดที่ซึ่งไม่มีกลิ่นซัลฟิวรัส, ซึ่งมีลักษณะเฉพาะที่ว่าเม็ดดังกล่าวถูกรวมตัวโดยใช้ แกรนูเลทที่ถูกเตรียมโดยอาศัยกระบวนการของการทำส่วนผสมออกฤทธิ์ให้เป็นแกรนูลแบบแห้ง เพียงอย่างเดียว, กับที่ส่วนเติมเนื้อยาถูกผสมก่อนการบีบอัด สิทธิบัตรยา The invention involves swallowable tablets with at least 80% by weight of N-acetyl cysteine (NAC) and at least one chemically acceptable drug additive, in particular Pellets which do not have a sulfurous odor, which have the characteristics that they are combined using Granulation is prepared by means of the process of making active ingredients into dry granulation. Alone, the body additive was mixed before the patent compression of the drug.
Claims (2)
Publications (3)
| Publication Number | Publication Date |
|---|---|
| TH1501007009A TH1501007009A (en) | 2017-07-13 |
| TH164760A true TH164760A (en) | 2017-07-13 |
| TH164760B TH164760B (en) | 2017-07-13 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201691242A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AZD9291 | |
| PH12015502535B1 (en) | Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes | |
| PH12015502608A1 (en) | Swallowable n-acetlcystene tablets | |
| EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
| WO2014179567A3 (en) | Methods and compositions for treating beta-thalassemia and sickle cell disease | |
| WO2016011297A3 (en) | Methods and related compositions for improved drug bioavailability and disease treatment | |
| JP2016108327A5 (en) | ||
| WO2015086838A3 (en) | A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation | |
| JP2016535794A5 (en) | Rapidly disintegrating solid dosage form | |
| MX2019010228A (en) | Composition for controlled release of physiologically active substances and process for its preparation. | |
| EA201650141A1 (en) | COMPOSITION FOR DETOXICATION OF THE ORGANISM | |
| WO2014165513A3 (en) | Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof | |
| WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
| EA202090913A1 (en) | COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON | |
| PH12016502272A1 (en) | Ceritinib formulation | |
| BR112017019364A2 (en) | solid dispersions | |
| TH164760A (en) | N-acetyl cysteine tablets that can be swallowed. | |
| EA201690395A1 (en) | STABLE PHARMACEUTICAL COMPOSITION CONTAINING BISOPROLOL AND RAMIPRIL | |
| TH164760B (en) | N-acetyl cysteine tablets that can be swallowed. | |
| MX2022013576A (en) | Composition for controlled release of physiologically active substances and process for its preparation. | |
| WO2015114656A3 (en) | Mucoadhesive tablet of pregabalin | |
| MA39009A (en) | Compositions pharmaceutiques comprenant un agent actif | |
| EA201791458A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT | |
| WO2015114655A3 (en) | Modified release tablet of pregabalin | |
| RU2010154205A (en) | SOLID MEDICINAL FORM OF MEMANTINE PREPARATIONS AND ITS SALTS |